key: cord-1042230-jg5p6qnf
authors: Seemann, T.; Lane, C.; Sherry, N.; Duchene, S.; Goncalves da Silva, A.; Caly, L.; Sait, M.; Ballard, S. A.; Horan, K.; Schultz, M. B.; Hoang, T.; Easton, M.; Dougall, S.; Stinear, T.; Druce, J.; Catton, m.; Sutton, B.; van Diemen, A.; Alpren, C.; Williamson, D.; Howden, B. P.
title: Tracking the COVID-19 pandemic in Australia using genomics
date: 2020-05-16
journal: nan
DOI: 10.1101/2020.05.12.20099929
sha: bbe4416bc89da02096035f58869f3cdeaee7761a
doc_id: 1042230
cord_uid: jg5p6qnf

BACKGROUND: Whole-genome sequencing of pathogens can improve resolution of outbreak clusters and define possible transmission networks. We applied high-throughput genome sequencing of SARS-CoV-2 to 75% of cases in the State of Victoria (population 6.24 million) in Australia. METHODS: Cases of SARS-CoV-2 infection were detected through active case finding and contact tracing. A dedicated SARS-CoV-2 multidisciplinary genomic response team was formed to enable rapid integration of epidemiological and genomic data. Phylodynamic analysis was performed to assess the putative impact of social restrictions. RESULTS: Between 25 January and 14 April 2020, 1,333 COVID-19 cases were reported in Victoria, with a peak in late March. After applying internal quality control parameters, 903 samples were included in genomic analyses. Sequenced samples from Australia were representative of the global diversity of SARS-CoV-2, consistent with epidemiological findings of multiple importations and limited onward transmission. In total, 76 distinct genomic clusters were identified; these included large clusters associated with social venues, healthcare facilities and cruise ships. Sequencing of sequential samples from 98 patients revealed minimal intra-patient SARS-CoV-2 genomic diversity. Phylodynamic modelling indicated a significant reduction in the effective viral reproductive number (Re) from 1.63 to 0.48 after the implementation of travel restrictions and population-level physical distancing. CONCLUSIONS: Our data provide a comprehensive framework for the use of SARS-CoV-2 genomics in public health responses. The application of genomics to rapidly identify SARS-CoV-2 transmission chains will become critically important as social restrictions ease globally. Public health responses to emergent cases must be swift, highly focused and effective.

The coronavirus disease pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global public health emergency on a scale not witnessed in living memory. First reports in December 2019 described a cluster of patients with pneumonia, linked to a market in Wuhan, China. 1,2 Subsequent testing revealed the presence of a previously unknown coronavirus, now termed SARS-CoV-2, with the associated disease termed COVID- 19. 2 Initial laboratory responses included early characterization and release of the viral whole genome sequence (strain Wuhan-Hu-1) in early January 2020, 2 which enabled rapid development of reversetranscriptase polymerase chain reaction (RT-PCR) diagnostics. 3 To date, laboratory testing has played a critical role in defining the epidemiology of the disease, informing case and contact management, and reducing viral transmission. 4 In addition to facilitating the development of diagnostic tests, whole genome sequencing (WGS) can be used to detect phylogenetic clusters of SARS-CoV-2, 5 with many laboratories now making genomic data publicly available. 6, 7 For other viral pathogens genomic surveillance has been used to detect and respond to putative transmission clusters, 8, 9 and to provide information on the possible source of individual cases. 10 To ensure maximal public health utility, genomics-informed public health responses require detailed integration of genomic and epidemiological data, which in turn requires close liaison between laboratories and public health agencies. Here, we combined extensive WGS and epidemiologic data to investigate the source of individual cases of COVID-19 in Victoria, Australia. This report describes the key findings from the first 1,333 cases of COVID-19 in our setting, and demonstrates the integration of genomics-based COVID-19 surveillance into public health responses.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05. 12.20099929 doi: medRxiv preprint

In the State of Victoria, Australia (population approximately 6.24 million) all samples positive for SARS-CoV-2 by RT-PCR are forwarded to the Doherty Institute Public Health Laboratories, 11 for confirmation and genomics analysis. We conducted a retrospective, observational study of all patients in Victoria with confirmed COVID-19 with a diagnosis prior to 14 April 2020, including collection of detailed demographic and risk factor information on each case. Epidemiological clusters were defined as clusters containing three or more cases with a common source exposure (e.g. healthcare facility).

To rapidly implement SARS-CoV-2 genomic analysis into local public health responses, a COVID-19 genomics response team was convened, including representatives from the state health department, virology laboratory, and the public health genomics laboratory (genomic epidemiologist, bioinformaticians and medical microbiologists). Laboratory and bioinformatic workflows were developed to support large-scale rapid processing of samples, enabling genomic sequencing and bioinformatic analysis of 96 samples in an approximately 45-hour time period. The response team held online meetings to enable interactive reporting of genomic epidemiological analyses and facilitate rapid translation of genomic findings into public health responses.

Detailed methods are provided in the Supplementary Appendix. In brief, extracted RNA from SARS-CoV-2 RT-PCR positives samples underwent tiled amplicon PCR using either ARTIC version 1 or version 3 primers 12 using published protocols, 13 and Illumina sequencing. Reads were aligned to the reference genome (Wuhan Hu-1; GenBank MN908947.3) and consensus sequences generated. We applied quality control checks on consensus sequences, requiring ≥80% genome recovered, ≤25 single nucleotide polymorphisms (SNPs) from the reference genome, and ≤300 ambiguous or missing bases for sequences to 'pass' QC (Supplementary Figure S1 ). For phylogenetic analysis, a single sequence was selected per patient, and genomic clusters defined as two or more related sequences using Cluster Picker 14 ; additionally, recently proposed lineages were also determined. 15 Intra-patient sequence . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 16, 2020. 

We conducted Bayesian phylodynamic analyses using the 903 genome samples from Victoria, sampled between 25 January and 14 April 2020 using BEAST2.5 (Supplementary Appendix). 16 We calibrated the molecular clock using the sample collection times, and inferred epidemiological dynamics assuming a birth-death skyline model including two intervals for Re estimated in the analysis. We assumed a duration of infection of 9.68 days to match independent epidemiological estimates reported by local mathematical modelling data. 17

Consensus sequences and Illumina sequencing reads were deposited into GenBank under BioProject PRJNA613958 (Supplementary Data). Consensus genome sequences are also available from https://github.com/MDU-PHL/COVID19-paper.

Associations between categorical data were made using a chi-squared test, and differences in nonnormally distributed numerical data using the Wilcoxon Rank sum test. All statistical analyses were performed using R (v.3.6.3).

Data were collected in accordance with the Victorian Public Health and Wellbeing Act 2008. Ethical approval was received from the University of Melbourne Human Research Ethics Committee (study number 1954615.3). All authors vouch for the integrity and completeness of data and analyses.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint 6

Over the study period, there were 1,333 laboratory-confirmed cases of COVID-19 in Victoria. Of these, 631/1,333 (54.2%) were male, and the median age was 47 years (IQR 29 to 61) ( Table 1 ). The majority of cases (827/1,333, 62.0%) were identified in returning travelers, most commonly from north-west Europe and the Americas, and 360 (27.0%) in known COVID-19 contacts (Table 1) . Cases in Victoria peaked in mid-March, then declined over the study period, consistent with population-level public health interventions ( Figure 1 ). In total, 134/1,333 (10.1%) cases were from an unknown source within Australia.

A total of 1,242 samples from 1,075 patients were sequenced during the study period, representing 80.7% of all cases (Supplementary Figure S2 ). There were no significant demographic differences between cases with and cases without included sequence data (Supplementary Table 1 Table 1 ).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint

In total, 737 samples belonged to a genomic cluster, representing 81.6% of the samples in the final dataset. Overall, 76 genomic clusters were identified, with a median of 5 cases per cluster (range 2 to 75, IQR 2-11 cases) and median duration of 13 days (IQR 5-22 days) ( Figure 3A) , consistent with repeated introduction and limited subsequent local transmission. Of the 76 clusters, 34 (45%) contained only cases reporting overseas travel; a further 34/76 clusters (45%) contained both travel-associated and locally-acquired cases, with the first sampled case reporting overseas travel in 27/34 (79%) of these clusters. There was strong concordance between epidemiological and genomic clusters, with a median of 100% (IQR 85-100%) of cases within an epidemiological cluster contained within a single dominant genomic cluster ( Figure 3B ).

Of the 81/134 sequenced cases (61%) with an epidemiologically unknown source of acquisition, 71 (88%) were identified within 24 genomic clusters, providing insight into potential sources of acquisition for these epidemiologically undefined cases. This information was provided to the genomics response team to inform public health investigation in these cases.

Several genomic clusters were investigated further due to their size and high-risk settings ( Figure 3 ).

For example, 48/51 (94%) cases in four epidemiological clusters associated with social venues in a specific area of metropolitan Melbourne were found within genomic cluster 19 (total 75 cases), providing genomic evidence for community transmission. Importantly, 16/75 cases (21%) in this cluster had no known epidemiological source of infection, and 7/75 cases (9%) were associated with an epidemiologically unlinked health service.

Genomic analysis was also used to exclude a putative transmission network involving four health services, epidemiologically linked by common healthcare workers or healthcare exposure. Preliminary epidemiological analysis suggested this network comprised 54 cases; however, genomic investigations revealed the cases fell within at least four distinct genomic clusters (clusters 9, 69, 54, and 27, Figure   . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint 8 3). On further investigation, three cases from two health services found in Cluster 54 (total 15 cases) were determined to have attended the same social event, excluding healthcare associated transmission in one health service. Among our dataset, 4/76 (5%) genomic clusters had >50% of cases associated with a cruise ship (Figure 3 ). 17/74 cases (23%) in these clusters had no history of overseas travel, indicating limited onwards transmission.

Sixty-three cases had more than one sample sequenced over the study period (median 2 sequences per case, range 2-5), with a median of 10 days between first and last sample (IQR 5-13 days) (Supplementary Table S2 and Supplementary Figure S4 ). The median intra-patient pairwise SNP distance was 0 (range 0-18 SNPs), compared to a median inter-patient pairwise SNP distance of 11 SNPs (range 0-27 SNPs). Three intra-patient pairs were outliers, having pairwise SNP distances of 7, 9 and 18 SNPs. On manual inspection, at least one sequence from each pair was found to have more ambiguous or missing base calls than the rest of the dataset, potentially contributing to the high number of intra-patient SNPs. In order to further assess reproducibility of SARS-CoV-2 sequencing, duplicate sequencing of the same clinical sample was also performed across different sequencing runs for ten samples, with zero SNP differences detected between consensus sequences. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint 9 (CI: 0.7 -1.0), consistent with intensive sequencing efforts in Victoria, and in accordance with the proportion of samples obtained for sequencing from cases in Victoria (1,075/1,333; 80.6%).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint

We provide a detailed picture of the emergence and limited onward spread of SARS-CoV-2 in Australia, representing the largest genomic epidemiological study of SARS-CoV-2 to date. The sheer scale and rapidity of the COVID-19 pandemic has necessitated swift and unprecedented public health responses, and the high proportion of cases with associated sequence data in our study provides unique genomic insights into the effects of public health interventions on the spread of SARS-CoV-2. The genomic clusters in our dataset reflect some of the key public health and epidemiological themes that have emerged globally for COVID-19.

First, consistent with epidemiological data, 76% of genomic clusters in our setting had at least 50% of cases associated with international travel, although in most instances, there was only limited onward transmission. The changing origin of travel-associated clusters in our dataset (Asia, Europe, North America) is in keeping with the temporal emergence of these areas as global 'hot-spots' for COVID- 19 , and in keeping with sequential international travel restrictions declared by the Australian Government 18 . Of note, 22% of travel-associated cases were 'sporadic' (i.e. not in a genomic cluster), providing genomic evidence for the positive effects of widespread public health messaging and selfisolation requirements for returning travelers. Moreover, we identified four genomic clusters that were associated with cruise ship passengers either returning to or disembarking in Melbourne. Throughout the global COVID-19 pandemic, cruise ships have been identified as 'amplification vessels' for COVID-19, with onward seeding into ports. 19 In Victoria, returning cruise ship passengers were differences between epidemiological and genomic modelling may be due to differences in underlying models and the expected lag between demographic processes and their effect on molecular variation, even for rapidly evolving pathogens 22 .

A major strength of our study is that we were able to sequence samples from approximately 80% of all cases in Victoria, facilitated by the centralized nature of public health laboratory services in our setting.

The high proportion of sequenced cases allowed us to address very specific queries from a public health perspective (e.g., whether case X belongs to cluster Y), enabling enhanced contact tracing when there was uncertainty around epidemiological information. Key to this effort was high-throughput sequencing using an amplicon-based approach, which allowed us to process a large number of samples in a short period of time. Stringent QC to ensure only high-quality consensus sequences entered the final alignment was particularly important when considering the minimal diversity in SARS-CoV-2 sequence . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05. 12.20099929 doi: medRxiv preprint data used to infer genomic clusters. 23, 24 While use of a predefined Ct value to select samples for SARS-CoV-2 genomic sequencing could be considered, 25 our use of QC parameters, rather than a Ct value, enabled the inclusion of additional samples for genomic analysis, with samples with Ct values >40 being successfully included. Of further note was our assessment of intra-patient diversity, representing the largest analysis of intra-patient SARS-CoV-2 diversity to date. Our observation of minimal intrapatient SARS-CoV-2 diversity is in keeping with other recent findings, 26 and provides additional evidence for the reproducibility of our sequencing and analysis.

In summary, we provide detailed genomic insights into the emergence and spread of SARS-CoV-2 in Australia and highlight the effect of public health interventions on the transmission of SARS-CoV-2.

Through a combination of rapid public health responses, extensive diagnostic testing and collective social responsibility, Australia has successfully navigated the first wave of the COVID-19 pandemic.

As social restrictions inevitably ease, the role of genomics will become increasingly important to rapidly identify and 'stamp out' possible transmission chains. Our data provide a framework for the future application of genomics in the response to COVID-19.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. * Cases travelling to more than one region were counted more than once . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A novel coronavirus from patients with pneumonia in China

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Report from the American Society for Microbiology COVID-19 International Summit

Phylogenetic network analysis of SARS-CoV-2 genomes

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Extensive hospital in-ward clustering revealed by molecular characterization of influenza A virus infection

Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study

HIV infection linked to injection use of oxymorphone in Indiana

Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in

ARTIC-nCoV2019 primer schemes (Github). 2020

Automated analysis of phylogenetic clusters

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis

COVID-19 advice for travellers

Public Health Responses to COVID-19 Outbreaks on Cruise Ships -Worldwide

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Death from Covid-19 of 23 Health Care Workers in China

Characteristics of and Important Lessons From the

COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Getting to the root of epidemic spread with phylodynamic analysis of genomic data

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures

Revealing COVID-19 transmission by SARS-CoV-2 genome sequencing and agent-based modelling

Virological assessment of hospitalized patients with COVID-2019

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

We thank the public health, clinical, and microbiology staff across Victoria who have been involved in the testing, clinical care and public health responses to COVID-19. The data collected through public health officers and microbiology laboratories are critical for public health genomics investigations. We also thank Nick Loman, Jonathon Jacobs, Duncan Maccannell and Karthik Gangavarapu for bioinformatics advice, and Josh Quick, George Taiaroa and Sara Zufan for assistance with obtaining ARTIC primers early in the pandemic. 

No author has any competing interests to declare. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05. 12.20099929 doi: medRxiv preprint to each other within the network as the density (number) of linkages between them increases, with cases in the same epidemiological cluster forming a spatially distinct group. Cases are colored by genomic cluster; cases where a sequence was not included primary analysis are colored white. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 16, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 16, 2020. . https://doi.org/10.1101/2020.05.12.20099929 doi: medRxiv preprint